Novo Nordisk on PHI
December 7, 2015
NOVO Nordisk has made a
submission to the government’s
Private Health Insurance (PHI)
committee, urging the retention of
the 30% rebate on extras in order
to keep supporting patients on
private prescription medication.
The submission warns that
removing the 30% rebate from
extra cover could lead to “perverse
incentives” which would see the
patient undergo more expensive
hospital care.
Novo Nordisk also urges the
adoption of a standard “overall
extras package” within private
health insurance offerings which
could include a set of core services
such as general dental, optical,
physiotherapy, psychology,
podiatry, speech therapy,
occupational therapy, health aids &
appliances and pharmacy.
Pharmacy extras cover should
include a set of key criteria including
a standard co-payment and TGA
approval, the submission adds.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Dec 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Dec 15
